David C. Lyden

54.2k citations
167 papers · 44.9k · 26 hit papers · h-index 70

Impact in

    • Extracellular vesicles in disease
    • Angiogenesis and VEGF in Cancer
  • Oncology top 0.2%
    • Cancer Cells and Metastasis

Papers in

    • Extracellular vesicles in disease 39
    • Angiogenesis and VEGF in Cancer 19
    • PI3K/AKT/mTOR signaling in cancer 3
    • Cancer Cells and Metastasis 17

David C. Lyden

162 papers receiving 44.0k citations

David C. Lyden's Hit Papers

The Space Omics and Medical Atlas (SOMA) and international astronaut biobank 2024 · 71 citations
710+4+8Years since publication10002.0k3.0k4.0k

Peers

David C. Lyden
Comparison fields: 5 of 125
  • Molecular Biology 18.9k
  • Oncology 5.0k
  • Genetics 1.7k
  • Cancer Research 1.7k
  • Hematology 1.4k
Replace Daniel J. Hicklin with:
Daniel J. Hicklin United States
Julian Downward United Kingdom
Shahin Rafii United States
Axel Ullrich Germany
Kohei Miyazono Japan
Jacqueline Bromberg United States
Frédéric J. de Sauvage United States
Lena Claesson Sweden
Harold L. Moses United States
Jon Christopher Aster United States
David C. Lyden relative to Daniel J. Hicklin United States Daniel J. Hicklin's profile →
Citations per field
00.5×2×4×6.2×
Daniel J. Hicklin · 1×
Citations per year

Countries citing papers authored by David C. Lyden

Since Specialization
Citations

This map shows the geographic impact of David C. Lyden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Lyden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Lyden more than expected).

Fields of papers citing papers by David C. Lyden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David C. Lyden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Lyden. The network helps show where David C. Lyden may publish in the future.

Co-authors

The 25 scholars most cited alongside David C. Lyden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David C. Lyden Line = papers co-authored together David C. Lyden links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 167 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Tumour exosome integrins determine organotropic metastasis
Hit paper breakdown →
20154267
2
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
Hit paper breakdown →
20123182
3
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Hit paper breakdown →
20052693
4
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
Hit paper breakdown →
20152282
5
Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis
Hit paper breakdown →
20161652
6
Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth
Hit paper breakdown →
20011592
7
Pre-metastatic niches: organ-specific homes for metastases
Hit paper breakdown →
20171529
8
Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-Ligand
Hit paper breakdown →
20021481
9
Double-stranded DNA in exosomes: a novel biomarker in cancer detection
Hit paper breakdown →
20141410
10
Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation
Hit paper breakdown →
20181400
11
Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration
Hit paper breakdown →
20031361
12
Tumor Response to Radiotherapy Regulated by Endothelial Cell Apoptosis
Hit paper breakdown →
20031346
13
The metastatic niche: adapting the foreign soil
Hit paper breakdown →
20091067
14
Exosome-Mediated Metastasis: Communication from a Distance
Hit paper breakdown →
20191039
15
Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers
Hit paper breakdown →
20201008
16
The perivascular niche regulates breast tumour dormancy
Hit paper breakdown →
2013931
17 1999774
18
CD133 expression is not restricted to stem cells, and both CD133+ and CD133– metastatic colon cancer cells initiate tumors
Hit paper breakdown →
2008771
19
Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration
Hit paper breakdown →
2010686
20
Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis
Hit paper breakdown →
2003642

About David C. Lyden

David C. Lyden is a scholar working on Molecular Biology, Oncology, Genetics, Hematology and Cardiology and Cardiovascular Medicine, having authored 167 papers that have together received 44.9k indexed citations. Recurring topics across this work include Extracellular vesicles in disease (39 papers), Angiogenesis and VEGF in Cancer (19 papers), Cancer Cells and Metastasis (17 papers), Glioma Diagnosis and Treatment (12 papers), Viral Infections and Immunology Research (6 papers), Spaceflight effects on biology (5 papers), Hematopoietic Stem Cell Transplantation (4 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). The work is most often cited by research in Molecular Biology (18.9k citations), Oncology (5.0k citations), Genetics (1.7k citations), Cancer Research (1.7k citations) and Hematology (1.4k citations). David C. Lyden has collaborated with scholars based in United States, Portugal and Japan. Frequent co-authors include Shahin Rafii, Bethan Psaila, Héctor Peinado, Rosandra Natasha Kaplan, Beate Heissig, Haiying Zhang, Robert Benezra, Koichi Hattori, Sérgio Dias and Candia M. Kenific. Their work appears in journals such as Cancer Cell, Nature, Nature Medicine, Nature Cell Biology and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact